Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Annarosaria De Chiara
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Journal of Cancer
Oncology
Related publications
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)
American Journal of Surgical Pathology
Anatomy
Forensic Medicine
Pathology
Surgery
A Network of Endogenous Metabolites Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Monocytic Leukemia
Biophysical Journal
Biophysics
PD-1 Receptor (PDCD1; PD-1; CD279); Programmed Cell Death 1 Ligand 1 (CD274 Molecule; PD-L1; B7-H1)
Science-Business eXchange
Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
Cancer immunology research
Cancer Research
Immunology
Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
P2.04-01 Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
